These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6750423)
81. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus. Dreyling KW; Wanner C; Schollmeyer P Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905 [TBL] [Abstract][Full Text] [Related]
83. The syndrome of hyporeninemic hypoaldosteronism. Knochel JP Annu Rev Med; 1979; 30():145-53. PubMed ID: 400485 [No Abstract] [Full Text] [Related]
84. [Clinical use of fludrocortisone acetate in congenital adrenal hyperplasia. Effect on plasma renin activity and aldosterone (author's transl)]. Tokuhiro E; Suwa S; Maesaka H Horumon To Rinsho; 1980; 28(3):345-51. PubMed ID: 6994941 [No Abstract] [Full Text] [Related]
85. [Hyporeninic hypoaldosteronism: pathogenetic importance of kidney parenchyma diseases and age]. Weidmann P; Maxwell MH; Winer R; Rowe P; Bursztein S; de Lima J Schweiz Med Wochenschr; 1974 Dec; 104(49):1805-8. PubMed ID: 4456600 [No Abstract] [Full Text] [Related]
86. Hyperkalemia in a diabetic due to renal tubular unresponsiveness to aldosterone. Bannister KM; Barratt LJ Aust N Z J Med; 1982 Feb; 12(1):63-6. PubMed ID: 7044358 [No Abstract] [Full Text] [Related]
87. [Hyporeninemic hypoaldosteronism with hypokalemic crises]. Cotrozzi G; Matteini M; Relli P; Lazzari T; Buzzelli G Recenti Prog Med; 1983 Aug; 74(8):901-9. PubMed ID: 6359299 [No Abstract] [Full Text] [Related]
88. [Acute kidney failure and the renin-angiotensin-aldosterone system]. Bystrovskiĭ VF Klin Med (Mosk); 1985 Apr; 63(4):13-6. PubMed ID: 3897697 [No Abstract] [Full Text] [Related]
89. Effect of glycyrrhizine on hyperkalemia due to hyporeninemic hypoaldosteronism in diabetes mellitus. Murakami T; Uchikawa T Life Sci; 1993; 53(5):PL63-8. PubMed ID: 8336514 [TBL] [Abstract][Full Text] [Related]
90. Hyporeninemic hypoaldosteronism in RMND1-related mitochondrial disease. Kömhoff M; Gracchi V; Dijkman H; Beck BB; Monnens L Pediatr Nephrol; 2024 Jan; 39(1):125-129. PubMed ID: 37450011 [TBL] [Abstract][Full Text] [Related]
91. [Diabetes mellitus and its complications in Japan. Studies on the cause and treatment of hyporeninemic selective hypoaldosteronism in diabetic nephropathy]. Fukuchi S Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1434-5. PubMed ID: 1684805 [No Abstract] [Full Text] [Related]
92. Hyperkalemia induced by indomethacin and naproxen and reversed by fludrocortisone. Mactier RA; Khanna R South Med J; 1988 Jun; 81(6):799-801. PubMed ID: 3375885 [TBL] [Abstract][Full Text] [Related]
93. Reversible hyperkalemia induced by flufenamic acid in asymptomatic hyporeninemic patient. Miyamori I; Sakai T; Ito T; Sugihara N; Ikeda M; Takeda Y; Takeda R Jpn J Med; 1985 Aug; 24(3):269-72. PubMed ID: 3906208 [TBL] [Abstract][Full Text] [Related]
95. Potassium tolerance in sickle-cell hemoglobinopathy. Mitnick P; Sterns R; Cox M Ann Intern Med; 1979 Aug; 91(2):319-20. PubMed ID: 464484 [No Abstract] [Full Text] [Related]
96. Investigations into the mechanisms of hyperkalemia following renal transplantation. DeFronzo RA; Goldberg M; Cooke CR; Barker C; Grossman RA; Agus ZS Kidney Int; 1977 May; 11(5):357-65. PubMed ID: 330924 [No Abstract] [Full Text] [Related]
97. A Japanese girl with aldosterone synthase deficiency requiring fludrocortisone until 10 years of age. Koyama S; Tsuboi T; Naganuma J; Arisaka O; Yoshihara S Pediatr Int; 2023; 65(1):e15625. PubMed ID: 37776040 [No Abstract] [Full Text] [Related]
98. Sickle cell nephropathy: new insights into its pathophysiology. de Jong PE; Statius van Eps LW Kidney Int; 1985 May; 27(5):711-7. PubMed ID: 3894760 [No Abstract] [Full Text] [Related]